This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergonzelli, G. E.
Right arrow Articles by Corthésy-Theulaz, I. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergonzelli, G. E.
Right arrow Articles by Corthésy-Theulaz, I. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2003, p. 3240-3246, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3240-3246.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Essential Oils as Components of a Diet-Based Approach to Management of Helicobacter Infection

G. E. Bergonzelli,* D. Donnicola, N. Porta, and I. E. Corthésy-Theulaz

Nestle Research Center, Lausanne, Switzerland

Received 30 December 2002/ Returned for modification 26 April 2003/ Accepted 7 July 2003

An increased density of Helicobacter pylori in the gastric mucosa can be associated with more severe gastritis and an increased incidence of peptic ulcers. Therefore, people with asymptomatic gastritis would certainly benefit from a nutritional approach to help them manage the infection and therefore decrease the risk of development of associated pathologies. We analyzed the activities of 60 essential oils against H. pylori P1 and identified 30 oils that affected growth, with in vitro inhibition zones ranging between 0.7 and 6.3 cm in diameter. We further analyzed the effects of 16 oils with different activities on H. pylori P1 viability. Fifteen showed strong bactericidal activities, with minimal bactericidal concentrations after 24 h ranging from 0.02 to 0.1 g/liter at pH 7.4. Even though slight variations in activities were observed, the essential oils that displayed the strongest bactericidal potentials against H. pylori P1 were also active against other Helicobacter strains tested. Among the pure constituents of different essential oils tested, carvacrol, isoeugenol, nerol, citral, and sabinene exhibited the strongest anti-H. pylori activities. Although oral treatment of H. pylori SS1-infected mice with carrot seed oil did not result in significant decreases in the bacterial loads in the treated animals compared to those in the control animals, in all experiments performed, the infection was cleared in 20 to 30% of carrot seed oil-treated animals. Our results indicate that essential oils are unlikely to be efficient anti-Helicobacter agents in vivo. However, their effects may not be irrelevant if one plans to use them as food additives to complement present therapies.


* Corresponding author. Mailing address: Nestle Research Center, P.O. Box 4, CH-1000 Lausanne 26, Switzerland. Phone: 41 21 785 80 44. Fax: 41 21 785 85 44. E-mail: gabriela.bergonzelli{at}rdls.nestle.com.


Antimicrobial Agents and Chemotherapy, October 2003, p. 3240-3246, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3240-3246.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Romano, M, Iovene, M R, Russo, M I, Rocco, A, Salerno, R, Cozzolino, D, Pilloni, A P, Tufano, M A, Vaira, D, Nardone, G (2008). Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J. Clin. Pathol. 61: 1112-1115 [Abstract] [Full Text]